866-997-4948(US-Canada Toll Free)

Healthcare, Regulatory and Reimbursement Landscape - Egypt

Published By :

GlobalData

Published Date : Feb 2013

Category :

Healthcare

No. of Pages : 171 Pages

Healthcare, Regulatory and Reimbursement Landscape - Egypt

Summary

GlobalData, the industry analysis specialist, has released its new report, Healthcare, Regulatory and Reimbursement Landscape - Egypt. The report is an essential source of information and analysis on Egypts healthcare, regulatory and reimbursement landscape. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory and reimbursement landscape and healthcare infrastructure. 

Most importantly, it provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. The report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalDatas team of industry experts.

Egypts population was 80 million in 2011 and is increasing due to a positive balance between the birth and death rate. Policymakers are now presented with the problem of an increasing unemployment rate due to a lack of clear monetary policies. The pharmaceutical market was estimated at $2.6 billion in 2010 and is expected to reach approximately $5.3 billion by 2020 at a Compound Annual Growth Rate (CAGR) of 7.2%. The medical devices market was estimated at approximately $766m in 2011 and is expected to reach $1 billion by 2020 at a CAGR of 3.8%. The positive trends in the Egyptian healthcare market can primarily be attributed to -
  • Increasing access to healthcare facilities
  • Proposed universal healthcare insurance
  • Revising pricing policies for pharmaceuticals
Scope

The report provides information on Egypts healthcare, regulatory and reimbursement landscape, and includes -
  • Overview of the pharmaceutical and medical devices markets, comprising size, segmentation and key drivers and barriers
  • Profiles and SWOT analysis of the major players in the pharmaceutical and medical devices market, namely GlaxoSmithKline (GSK), Sanofi, Novartis, Egyptian International Pharmaceutical Industries Company (EIPICO) and South Egypt Drug Industries Company (SEDICO). The major players covered for the medical devices market are F. Hoffmann-La Roche, Fresenius Medical Care, Gambro, B. Braun Melsungen and GSK.
  • Insightful review of the reimbursement and regulatory landscape, including details of the healthcare reimbursement process, regulatory agencies and approval processes for new drugs
  • Detailed analysis of the political and economic environment, including economic indicators, demographics, and healthcare infrastructure and expenditure
  • Overview of the opportunities for and challenges to growth in the healthcare market
Reasons to buy

This report will enhance your decision-making capability by allowing you to -
  • Develop business strategies by understanding the trends shaping and driving Egypts healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Egypts healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership
  • Identify, understand and capitalize on the opportunities and challenges in Egypts healthcare market
Table of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 9

2 Introduction 11
2.1 Report Guidance 11

3 Overview of the Pharmaceutical and Medical Device Market 12
3.1 Pharmaceutical Market 12
3.1.1 Market Overview 12
3.1.2 Supply Channels 15
3.1.3 Market Segments 16
3.1.4 Major Therapeutic Areas 20
3.1.5 Major Players 22
3.2 Medical Device Market 43
3.2.1 Market Overview 43
3.2.2 Overview of Top Five Segments 45
3.2.3 Major Players 56
3.3 Market Drivers and Barriers 74
3.3.1 Drivers 74
3.3.2 Barriers 74

4 Market Access 76
4.1 Reimbursement and Payer Landscape 76
4.1.1 Overview of Healthcare System 76
4.1.2 Reimbursement Process 77
4.1.3 Overview of Insurance Providers 78
4.1.4 Patient Share of Healthcare Spending 82
4.1.5 Drug Price Trends 83
4.1.6 Pricing Policies 84
4.2 Regulatory Landscape 85
4.2.1 Overview of Regulatory Agencies 85
4.2.2 Drug Approval Procedure for Pharmaceutical Products 86
4.2.3 New Medical Device Approval Process 89
4.2.4 Licensing Process for Pharmaceutical Manufacturing 91
4.2.5 Licensing Process for Pharmaceutical Exports and Imports 92
4.2.6 Intellectual Property Rights 92
4.2.7 Clinical Trial Regulations 95
4.2.8 Pharmaceutical Advertising Regulations 95
4.2.9 Pharmacy Regulations 97
4.2.10 Labeling and Packaging Regulations 98

5 Country Analysis 99
5.1 Political Environment 99
5.1.1 Political Structure 99
5.1.2 Analysis of the Current Political Environment 99
5.1.3 Healthcare Policy Initiatives 100
5.2 Economic Landscape 101
5.3 Economic Indicators 103
5.3.1 Gross Domestic Product 103
5.3.2 Gross National Income 106
5.3.3 Inflation 107
5.3.4 Currency Exchange Rate 110
5.3.5 Foreign Direct Investment 111
5.3.6 Foreign Exchange Reserves 112
5.3.7 Trade Balance 113
5.3.8 Gross Fiscal Deficit 115
5.3.9 Gross Domestic Debt 116
5.3.10 Government Structural Balance 117
5.3.11 Major Industries 118
5.4 Demographics 119
5.4.1 Population 119
5.4.2 Education and Literacy 135
5.4.3 Employment 137
5.4.4 Disease Burden 138
5.5 Healthcare Infrastructure 140
5.5.1 Healthcare Facilities 140
5.5.2 Healthcare Parameters 144
5.5.3 Environmental Health 146
5.5.4 Healthcare Personnel 151
5.6 Healthcare Expenditure 153
5.6.1 Pharmaceutical Expenditure 154
5.6.2 Components of Healthcare Spending 155
5.6.3 Share of Public and Private Sectors 156
5.6.4 Spending in Pharmaceutical R&D 157
5.7 Trade Associations 158
5.7.1 Arab Union of Manufacturers of Pharmaceuticals and Medical Appliances 158
5.7.2 Federation of Egyptian Industries 158
5.7.3 Egyptian Pharmaceutical Students Federation 158
5.7.4 Insurance Federation of Egypt 158
5.8 Trade Fairs 159

6 Opportunities and Challenges 160
6.1 Opportunities 160
6.2 Challenges 160

7 Appendix 162
7.1 Abbreviations 162
7.2 Bibliography 163
7.3 Methodology 169
7.3.1 Coverage 170
7.3.2 Secondary Research 170
7.3.3 Forecasting 170
7.3.4 Primary Research 170
7.3.5 Expert Panel Validation 171
7.4 Contact Us 171
7.5 Disclaimer 171

List of Table


Table 1: Pharmaceutical Market, Egypt, Revenue ($bn), 2005-2010 13
Table 2: Pharmaceutical Market, Egypt, Revenue Forecast ($bn), 2011-2020 14
Table 3: Distribution Channel, Egypt, Price Margins (%), 2012 15
Table 4: Drugs Going Off-Patent, Global, Revenue ($m), 2011-2015 16
Table 5: Over-the-Counter Drugs Market, Egypt, Revenue ($m), 2006-2011 17
Table 6: Over-the-Counter Drug Use, Egypt, Segment Share (%), 2009 18
Table 7: Major Therapeutic Areas, Egypt, Hospital Admissions (000), 2011 20
Table 8: Major Products, GlaxoSmithKline, Global, Revenue ($m), 2011 22
Table 9: Late-Stage Pipeline, GlaxoSmithKline, 2012 23
Table 10: Major Products, Sanofi, Global, Revenue ($m), 2011 27
Table 11: Late-Stage Pipeline, Sanofi, 2012 28
Table 12: Major Products, Novartis, Global, Revenue ($m), 2011 31
Table 13: Planned Filings, Novartis, 2012 to

List of Chart


Figure 1: Pharmaceutical Market, Egypt, Revenue ($bn), 2005-2010 13
Figure 2: Pharmaceutical Market, Egypt, Revenue Forecast ($bn), 2011-2020 14
Figure 3: Distribution Channels, Egypt, 2012 15
Figure 4: Over-the-Counter Drugs Market, Egypt, Revenue ($m), 2006-2011 17
Figure 5: Over-the-Counter Drug Use, Egypt, Segment Share (%), 2009 18
Figure 6: Major Therapeutic Areas, Egypt, Hospital Admissions (000), 2011 20
Figure 7: Medical Device Market, Egypt, Revenue ($m), 20062011 43
Figure 8: Medical Device Market, Egypt, Revenue Forecast ($m), 2012-2020 44
Figure 9: Medical Device Market, Egypt, Revenue by Segment ($m), 2011 45
Figure 10: Nephrology and Urology Devices Market, Egypt, Revenue ($m), 2006-2011 46
Figure 11: Nephrology and Urology Devices Market, Egypt, Sales Trend for Major Players*, 2006-2011 47
Figure 12: In Vitro Diagnostics Market, Egypt, Revenue ($m), 2006-2011 48
Figure 13: In Vitro Diagnostic Devices Market, Egypt, Sales Trend for Major Players*, 2006-2010 49
Figure 14: Diabetes Care Devices Market, Egypt, Revenue ($m), 2006-2011 50
Figure 15: Diabetes Care Devices Market, Egypt, Sales Trend for Major Players*, 2006-2011 51
Figure 16: Drug Delivery Devices Market, Egypt, Revenue ($m), 2006-2011 52
Figure 17: Drug Delivery Devices Market, Egypt, Sales Trend for Major Players*, 2006-2010 53
Figure 18: Cardiovascular Devices Market, Egypt, Revenue ($m), 2006-2011 54
Figure 19: Cardiovascular Devices Market, Egypt, Sales Trend for Major Players*, 2006-2011 55
Figure 20: Major Medical Device Companies, Egypt, Revenue ($m), 2010 56
Figure 21: Healthcare Market, Egypt, Drivers and Barriers, 2012 75
Figure 22: Key Influencers in Decision-Making Process in Healthcare System, Egypt, 2012 76
Figure 23: Public Insurance Reform Milestones, Egypt, 1964-2012 78
Figure 24: HIO Beneficiaries, Egypt, Share (%), 2010 79
Figure 25: Source of HIO Healthcare Spending, Egypt, Share (%), 2009 80
Figure 26: HIO Expenditure by Provider, Egypt, Share (%), 2009 81
Figure 27: Healthcare Spending, Egypt, Patient Share (%), 2005-2010 82
Figure 28: Inflation, Healthcare, Egypt, Annual Growth (%), 2006-2011 83
Figure 29: Structure of the Drug Regulatory Authority, Egypt, 2012 85
Figure 30: Overview of General Drug Application Process, Egypt, 2012 87
Figure 31: Application Process for Local New Drug, Egypt, 2012 87
Figure 32: Application Process for Imported Generic and New Drugs, Egypt, 2012 88
Figure 33: Application Process for Local Generic Drugs, Egypt, 2012 88
Figure 34: Medical Device Registration Process, Egypt, 2012 90
Figure 35: Licensing Process for Manufacturing Site, Egypt, 2012 91
Figure 36: Licensing Process for New Production Line, Egypt, 2012 91
Figure 37: Patent Registration Process, Egypt, 2012 94
Figure 38: Advertisement Registration Process, Egypt, 2012 96
Figure 39: Pharmacy Establishment Process, Egypt, 2012 97
Figure 40: GDP Per Capita ($), Egypt, 2006-2011 103
Figure 41: GDP Per Capita ($), Egypt, Forecast, 2012-2020 104
Figure 42: GDP, Egypt, Annual Growth (%), 2006-2011 105
Figure 43: GNI Per Capita ($), Egypt, 2006-2011 106
Figure 44: Average Consumer Price Index, Egypt, 2006-2011 107
Figure 45: Average Consumer Price, Egypt, Annual Change (%), 2006-2011 108
Figure 46: Average Consumer Price, Egypt, Annual Change (%), Forecast, 2012-2020 109
Figure 47: Currency Exchange Rate (EGP/$), Egypt, 2006-2011 110
Figure 48: Foreign Direct Investment ($bn), Egypt, 2006-2011 111
Figure 49: Foreign Exchange Reserves ($bn), Egypt, 2006-2011 112
Figure 50: Imports ($bn), Egypt, 2006-2011 113
Figure 51: Exports ($bn), Egypt, 2006-2011 114
Figure 52: Gross Fiscal Deficits (% of GDP), Egypt, 2006-2011 115
Figure 53: Gross Domestic Debt ($bn), Egypt, 2006-2011 116
Figure 54: General Government Structural Balance ($bn), Egypt, 2006-2011 117
Figure 55: Major Industries, Egypt, GDP ($bn), 2011 118
Figure 56: Population (m), Egypt, 2006-2011 119
Figure 57: Population (m), Egypt, Forecast, 2012-2020 120
Figure 58: Urban and Rural Population, Egypt, Share (%), 2006-2011 121
Figure 59: Urban and Rural Population, Egypt, Share (%), Forecast, 2012-2020 122
Figure 60: Age Groups, Egypt, Population Distribution (%), 2006-2011 123
Figure 61: Age Groups, Egypt, Population Distribution (%), Forecast, 2012-2020 124
Figure 62: Births (Per 1,000 Population), Egypt, 2006-2011 125
Figure 63: Mortality (Per 1,000 Population), Egypt, 2006-2011 126
Figure 64: Major Causes of Mortality (%), Egypt, 2010 127
Figure 65: Children <5 Years, Egypt, Mortality Rate (Per 1,000 Live Births), 2006-2011 128
Figure 66: Immunization Rate (%), Egypt, 2005-2010 129
Figure 67: Major Causes of Male Mortality (%), Egypt, 2010 130
Figure 68: Major Causes of Female Mortality (%), Egypt, 2010 131
Figure 69: Gender Ratio (Females Per 1,000 Males), Egypt, 2006-2011 132
Figure 70: Life Expectancy at Birth (Years), Egypt, 2006-2011 133
Figure 71: Life Expectancy at Birth (Years), Egypt, Forecast, 2012-2020 134
Figure 72: Levels of Education, Egypt, Student Enrollment (000), 2011 135
Figure 73: Higher Education, Egypt, Student Enrollment (%), 2011 136
Figure 74: Unemployment Rate (%), Egypt, 2006-2011 137
Figure 75: Hospital Admissions by Specialty (000), Egypt, 2011 138
Figure 76: Major Diseases, Egypt, DALYs (Per 100,000 Population), 2004 139
Figure 77: Public Hospitals, Egypt, 2006-2011 140
Figure 78: Hospitals by Specialty, Egypt, 2011 141
Figure 79: Health Centers, Egypt, 2006-2011 142
Figure 80: Public-Private Hospital Beds (000), Egypt, 2006-2011 143
Figure 81: Hospital Beds (Per 1,000 Population), Egypt, 2005-2010 144
Figure 82: Physicians (Per 10,000 Population), Egypt, 2006-2011 145
Figure 83: CO2 Emissions (Million Tons), Egypt, 2005-2010 146
Figure 84: PM-10 Emissions (gm/cubic meter), Egypt, 2005-2010 147
Figure 85: Biochemical Oxygen Demand (mg/l), Egypt, 2005-2010 148
Figure 86: Sources of Solid Waste, Share (%), Egypt, 2009 149
Figure 87: Waste Handling, Egypt, Share (%), 2010 150
Figure 88: Nurses (Per 10,000 Population), Egypt, 2006-2011 151
Figure 89: Pharmacists (Per 10,000 Population), Egypt, 2006-2011 152
Figure 90: Dentists (Per 10,000 Population), Egypt, 2006-2011 152
Figure 91: Healthcare Expenditure (% of GDP), Egypt, 2005-2010 153
Figure 92: Pharmaceutical Expenditure (% of Total Healthcare Expenditure), Egypt, 2005-2010 154
Figure 93: Healthcare Expenditure, Egypt, Share of Major Components (%), 2009 155
Figure 94: Healthcare Expenditure, Egypt, Share (%), 2005-2010 156
Figure 95: Source of Healthcare Expenditure, Egypt, Share (%), 2009 157
Figure 96: Opportunities and Challenges, Healthcare Market, Egypt, 2012 161

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *